Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications

Archive ouverte

Blum, Yuna | Meiller, Clément | Quetel, Lisa | Elarouci, Nabila | Ayadi, Mira | Tashtanbaeva, Danisa | Armenoult, Lucile | Montagne, François | Tranchant, Robin | Renier, Annie | de Koning, Leanne | Copin, Marie-Christine | Hofman, Paul | Hofman, Véronique | Porte, Henri | Le Pimpec-Barthes, Françoise | Zucman-Rossi, Jessica | Jaurand, Marie-Claude | de Reyniès, Aurélien | Jean, Didier

Edité par CCSD ; Nature Publishing Group -

International audience. Malignant pleural mesothelioma (MPM) is recognized as heterogeneous based both on histology and molecular profiling. Histology addresses inter-tumor and intra-tumor heterogeneity in MPM and describes three major types: epithelioid, sarcomatoid and biphasic, a combination of the former two types. Molecular profiling studies have not addressed intra-tumor heterogeneity in MPM to date. Here, we use a deconvolution approach and show that molecular gradients shed new light on the intra-tumor heterogeneity of MPM, leading to a reconsideration of MPM molecular classifications. We show that each tumor can be decomposed as a combination of epithelioid-like and sarcomatoid-like components whose proportions are highly associated with the prognosis. Moreover, we show that this more subtle way of characterizing MPM heterogeneity provides a better understanding of the underlying oncogenic pathways and the related epigenetic regulation and immune and stromal contexts. We discuss the implications of these findings for guiding therapeutic strategies, particularly immunotherapies and targeted therapies.

Suggestions

Du même auteur

Genetic alterations of malignant pleural mesothelioma: association to tumor heterogeneity and overall survival Author names

Archive ouverte | Quetel, Lisa | CCSD

International audience. Development of precision medicine for malignant pleural mesothelioma (MPM) requires a deep knowledge of tumor heterogeneity. Histologic and molecular classifications and histo-molecular gradi...

Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2 , in Malignant Pleural Mesothelioma

Archive ouverte | Tranchant, Robin | CCSD

International audience. Purpose: To better define malignant pleural mesothelioma (MPM) heterogeneity and identify molecular subtypes of MPM, we focus on the tumor suppressor gene LATS2, a member of the Hippo signali...

Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma

Archive ouverte | Tranchant, Robin | CCSD

International audience. OBJECTIVES:Malignant pleural mesothelioma (MPM) is an aggressive tumor with limited therapeutic options, requiring the development of efficient targeted therapies based on molecular phenotype...

Chargement des enrichissements...